This week, the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration announced their “Safe Importation Action Plan.” While patients are rightfully concerned about the...
PhRMA remains committed to working with lawmakers to ensure patients can afford and access their medicines, but importation schemes that put patient safety at risk will never be the right approach.
PhRMA is committed to working with lawmakers to ensure patients can access and afford their medicines, but importation schemes that put patient safety at risk are the wrong approach. In a recent...
Updated 3/5/2019 Ensuring patients receive already negotiated savings on their medicines could save certain patients across seven states up to $2,360 a year, according to new analyses from Milliman.
Pharmaceutical Research and Manufacturers of America® 950 F Street, NW Suite 300, Washington, DC 20004